A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, 1 Week, Dose Comparison Study to Evaluate the Efficacy, Safety, and Tolerability of MPC-004 in Patients With an Acute Gout Flare.
Latest Information Update: 12 Jun 2013
At a glance
- Drugs Colchicine (Primary)
- Indications Gouty arthritis; Musculoskeletal pain
- Focus Registrational; Therapeutic Use
- Acronyms AGREE
- Sponsors Takeda
- 08 Nov 2010 Results of poc-hoc tolerability analysis presented at the 74th Annual Scientific Meeting of the American College of Rheumatology
- 21 Jan 2010 Results published in Arthritis and Rheumatism.
- 29 Oct 2009 Secondary endpoint results presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology and the 44th Annual Meeting of the Association of Rheumatology Health Professionals.